Neutrophils re-entering the circulation from a primary site of inflammation: Physiological or pathological?
In plain English
AI plain-English summaryNeutrophils—the immune system’s first responders—sometimes crawl out of a blood vessel toward an infection, then turn around and re-enter the bloodstream. This project investigates why they do that, and whether the reversal helps or harms the body. Most research assumes neutrophils exit a blood vessel and stay put. But the applicant has shown that some neutrophils perform reverse transendothelial migration (rTEM), and that these cells carry an activated, pro-inflammatory state linked to damage in distant organs like the lungs or kidneys. What remains unknown is how common rTEM neutrophils are, what molecular markers define them, and whether they play a role in ageing. The project will also test a new idea: that rTEM neutrophils might sometimes protect the host against pathogens, rather than just causing collateral harm. This is fundamental science. It does not promise a new drug or diagnostic tomorrow. But understanding why a subset of neutrophils re-enters circulation—and whether that behaviour is physiological or pathological—could reshape how researchers think about immune-driven tissue damage in sepsis, chronic inflammation, and age-related disease. Similar discoveries about immune cell behaviour have, in the past, opened entirely new avenues for therapy.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know